Urinary tract infections and genital mycotic infections associated with SGLT ‑2 inhibitors: an analysis of the FDA Adverse event Reporting system

CONCLUSIONS: Data mining in the FAERS database suggests strong association between SGLT-2 inhibitors and UTIs/GMIs. These findings provide real-world evidence on the potential risk of UTIs/GMIs related to SGLT-2 inhibitors.PMID:38009230 | DOI:10.1080/14740338.2023.2288897

Source: Expert Opinion on Drug Safety - November 27, 2023 Category: Drugs & Pharmacology Authors: Ting Yang Ying Zhou Yimin Cui Source Type: research